Open Access Open Badges Research

Inter-laboratory validation of the measurement of follicle stimulating hormone (FSH) after various lengths of frozen storage

Jessica Scriver1, Valerie L Baker2, Steven L Young3, Barry Behr2 and Lisa M Pastore4*

Author Affiliations

1 School of Medicine, University of Virginia, Charlottesville, VA 22908-0712, USA

2 OB/GYN Department, Stanford University, CA 94305, USA

3 OB/GYN Department, University of North Carolina, Chapel Hill, NC 27599-7570, USA

4 OB/GYN Department, University of Virginia, Charlottesville, VA 22908-0712, USA

For all author emails, please log on.

Reproductive Biology and Endocrinology 2010, 8:145  doi:10.1186/1477-7827-8-145

Published: 29 November 2010



Serum follicle stimulating hormone (FSH) levels are used clinically to evaluate infertility, pituitary and gonadal disorders. With increased frequency of research collaborations across institutions, it is essential that inter-laboratory validation is addressed.


An inter-laboratory validation of three commercial FSH immunoassays was performed with human serum samples of varying frozen storage length (2 batches of 15 samples each) at -25 degree C. Percentage differences and Bland-Altman limits of agreement were calculated.


The inter- and intra-laboratory consistency of FSH values with the same assay manufacturer was much higher after shorter-term storage (frozen for less than 11 months, mean percentage degradation less than 4%) than after long-term storage (2-3 years, mean percentage degradation = 23%). Comparing assay results from different manufacturers, there was similar overall long term degradation as seen with the same manufacturer (-25%), however the degradation was greater when the original FSH was greater than 20 mIU/mL relative to less than 10 mIU/mL (p < 0.001 trend test).


The findings suggest that degradation of serum samples stored between 11 months and 2-3 years at -25 degrees C can lead to unstable FSH measurements. Inter-laboratory variability due to frozen storage time and manufacturer differences in assay results should be accounted for when designing and implementing research or clinical quality control activities involving serum FSH at multiple study sites.